Use of Parathyroid Hormone for Treating Periodontal Disease and for Other Dental Applications
OwnerJohn Henry Kregeinventor
Life of this patent
Estimating the term…
Abstract
Method for treating or preventing periodontal disease associated with mild to severe alveolar bone loss, and for improving the prognosis of dental implant procedures by administering human parathyroid hormone to a patient in need thereof.
Claims20
A method for the treatment of periodontal disease in a human patient comprising administration of human parathyroid hormone in a daily dose of 20 μg to 30 μg.
(canceled)
(canceled)
(canceled)
A method to improve the prognosis of a dental implant procedure in a patient having inadequate alveolar bone mass, comprising administering human parathyroid hormone to said patient at a daily dose of 20 μg to 30 μg for a period of from about 3 months to about 6 months prior to said procedure.
A method to accelerate osseointegration of a dental implant in a patient following placement of an implant, comprising administration of human parathyroid hormone at a daily dose of 20 μg to 30 μg.
Dependencies are inferred from the claim text.